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INTRODUCTION 
Musculoskeletal activity has the potential to both improve and compromise decompression safety. Exercise 
enhances inert gas elimination during oxygen breathing prior to decompression (prebreathe), but it may also 
promote bubble nuclei formation (nucleation), which can lead to gas phase separation and bubble growth and 
increase the risk of decompression sickness (DCS). The timing, pattern and intensity of musculoskeletal activity and 
the level of tissue supersaturation may be critical to the net effect. Understanding the relationships is important to 
evaluate exercise prebreathe protocols and quantify decompression risk in gravity and microgravity environments. 
Data gathered during NASA's Prebreathe Reduction Program (PRP) studies combined oxygen prebreathe and 
exercise followed by low pressure (4.3 psi; altitude equivalent of 30,300 ft [9,235 m]) microgravity simulation to 
produce two protocols used by astronauts preparing for extravehicular activity. Both the Phase II/CEVIS (cycle 
ergometer vibration isolation system) and ISLE (in-suit light exercise) trials eliminated ambulation to more closely 
simulate the microgravity environment. The CEVIS results (35 male, 10 female) serve as control data for this 
NASA/Duke study to investigate the influence of ambulation exercise on bubble formation and the subsequent risk 
of DCS.  
 
METHODS 
Four experiments will replicate the CEVIS exercise-enhanced oxygen prebreathe protocol, each with a different 
exception. The first of these is currently underway. Experiment 1 – Subjects complete controlled ambulation 
(walking in place with fixed cadence and step height) during both preflight and at 4.3 psi instead of remaining non-
ambulatory throughout. Experiment 2 – Subjects remain non-ambulatory during the preflight period and 
ambulatory at 4.3 psi. Experiment 3 – Subjects ambulate during the preflight period and remain non-ambulatory at 
4.3 psi. Experiment 4 – The order of heavy and light exercise employed in the CEVIS protocol is reversed, with the 
light exercise occurring first (subjects remain non-ambulatory throughout). Decompression stress is assessed with 
non-invasive ultrasound during each of 14 epochs of a 4 hour simulated spacewalk at 4.3 psi; aural Doppler is used 
to monitor bubbles (Spencer grade 0-IV scale) passing through the pulmonary artery, and two-dimensional 
echocardiographic imaging is used to look for left ventricular gas emboli (LVGE; the presence of which is a test 
termination criterion). Venous blood is collected at baseline and twice following repressurization to determine if the 
decompression stress is correlated with microparticles (cell fragments) accumulation. The plan is to test 25-50 
subjects in each experiment. Fisher Exact Tests (one-tailed) are used to compare test and control groups. Trials are 
suspended when the DCS or grade IV VGE observations reach 70% confidence of DCS risk >15% and grade IV 
VGE risk >20%.  
 
RESULTS 
Experiment 1 was concluded with 20 complete trials (15 male, 5 female) since the statistical outcome would not 
change with five additional trials. The observed DCS was significantly greater in Experiment 1 than in CEVIS trials 
(4/20 [20%] vs. 0/45 [0%], respectively, p=0.007), as was the frequency of peak grade IV VGE (6/21 [29%; 
including one additional subject that presented grade IV VGE but whose trial was ended before completion when 
LVGE were observed] vs. 3/45 [7%], respectively, p=0.024). Experiment 3 trials are now underway, with 11 trials 
completed (10 male, 1 female). Preliminary results indicate no difference in observed DCS between Experiment 3 
and CEVIS trials (1/11 [9%] vs. 0/45 [0%], respectively, p=0.196), or between Experiment 3 and Experiment 1 trials 
(p=0.405). The frequency of peak grade IV VGE in Experiment 3 (2/11 [18%]) did not differ from CEVIS or 
Experiment 1 trials (p=0.251 and p=0.425, respectively). Microparticle patterns are widely variable and still under 
analysis. 
 
DISCUSSION 
The results of the Experiment 1 trials support the thesis that decompression stress is increased by ambulation 
exercise, given the higher incidence of DCS and grade IV VGE when compared to the non-ambulatory PRP CEVIS 
trials. Experiment 3 trials are incomplete, but suggest that the effect of ambulation during ground level preflight 
oxygen breathing alone, when subjects are undersaturated with inert gas, may not differ in risk from ambulation at 
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both preflight and spacesuit pressures, the latter when subjects are supersaturated with inert gas. Further trials are 
needed to confirm the relative effects of ambulation in undersaturated vs. supersaturated states and to determine 
whether light exercise facilitates the removal of heavy exercise-induced nucleation (Experiment 4).  
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Musculoskeletal activity may improve or compromise decompression safety. We evaluated ambulation exercise 
associated with simulated spacewalk. Decompression sickness was higher when ambulation was conducted at both 
preflight and spacesuit pressures but, tentatively, not when at preflight pressure alone (4/20 and 1/11 vs. 0/45, 
p=0.007 and p=0.196; Fisher Exact). Additional trials may further resolve effects.  
 
 
 
